Search results
CMS Redesigns the Medicare Part D Prescription Drug Program Beginning in 2025 | JD Supra
JD Supra· 4 days agoThe Final Program Instructions reflect a newly defined standard Part D benefit design through several changes or enhancements to the Part D program beginning in 2025. Of those changes or enhancements ...
The average retired American faces these new Medicare changes in 2025
TheStreet.com· 4 hours agoA policy announced by the Centers for Medicare and Medicaid Services involves maximum out-of-pocket expenses for seniors. There are many concerns Americans regularly confront ...
Medicare Part D Plans Poorly Cover Adalimumab Biosimilars
Medscape· 21 hours agoThis narrow coverage limits the cost-saving potential of these biosimilar competitors, expert said.
What Happened to Social Security Under Trump, Biden and 13 Other Presidents
GoBankingRates via AOL· 10 hours agoAs people grow older, their incomes decline and their healthcare expenses grow. Before Social...
Blend Extra: Learning Medicare Isn't Scary When You Have Jerry!
TMJ4 Milwaukee· 1 day agoJerry Wilson of Carpenter Marketing Group is back today to share some ways for Medicare individuals...
Analysis shows US couples aged 65-plus need $350,000 in savings to cover health care expenses in...
Moneywise via AOL· 3 days agoHere...a couple, both aged 65-plus, enrolled in a Medigap plan with average premiums in 2023 would...
New Jersey Statutory Update Part I | JD Supra
JD Supra· 19 hours agoLast year was no different, and the discussion below highlights some of those statutes, such as statutes further regulating pharmacy benefit managers, requiring manufacturers to report an increase ...
JD Supra: Better Health Care Newsletter
JD Supra· 10 hours agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big Pharma in recent years has flouted that charitable intent.
Fox News anchor in spat with Biden campaign over ‘blatant lie’ smear, and he has receipts
BizPac Review· 2 days agoThe Biden-Harris campaign is so sure that it won’t be called out on its lies by the corrupt media that it baselessly smeared Fox News anchor John Roberts for telling the truth and he’s pushing ...
2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
Zacks via Yahoo Finance· 1 day agoZacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite...
